Guggenheim Says Bausch Health Companies (BHC) Sell-Off 'Overdone'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance
February 19, 2020 6:59 AM ESTLAVAL, Quebec, Feb. 19, 2020 /PRNewswire/ --Â
Fourth-Quarter 2019 Financial Results Revenues of $2.224 Billion GAAP Cash Generated from Operations of $234 Million GAAP Net Loss of $1.516 Billion Adjusted EBITDA (non-GAAP)1 of $898 Million Full-Year 2019 Financial Results Revenues of $8.601 Billion GAAP Cash Generated from Operations of $1.501 Billion GAAP Net Loss of $1.788 Billion Adjusted EBITDA (non-GAAP)1 of $3.571 Billion Delivered Total Company Reported Revenue Growth of 5% in the Fourth Quarter and 3% for... More
